Effect of prasugrel for stent implantation in patients with acute coronary syndrome
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Prasugrel (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- Acronyms PACS study
- 03 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Mar 2017 Planned End Date changed from 31 Dec 2015 to 31 Mar 2017.
- 25 Aug 2015 Planned End Date 31 Dec 2015 added as reported by University Hospital Medical Information Network - Japan.